Cargando…
Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child
Charcot-Marie-Tooth disease (CMT) refers to a genetically heterogeneous group of disorders which cause a peripheral motor and sensory neuropathy. The overall prevalence is 1 in 2500 individuals. Mutations in the MFN2 gene are the commonest cause for the axonal (CMT2) type. We describe a Caucasian 5-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243894/ https://www.ncbi.nlm.nih.gov/pubmed/28063088 http://dx.doi.org/10.1007/s10048-016-0504-2 |
_version_ | 1782496597988343808 |
---|---|
author | Schon, Katherine Spasic-Boskovic, Olivera Brugger, Kim Graves, Tracey D. Abbs, Stephen Park, Soo-Mi Ambegaonkar, Gautam Armstrong, Ruth |
author_facet | Schon, Katherine Spasic-Boskovic, Olivera Brugger, Kim Graves, Tracey D. Abbs, Stephen Park, Soo-Mi Ambegaonkar, Gautam Armstrong, Ruth |
author_sort | Schon, Katherine |
collection | PubMed |
description | Charcot-Marie-Tooth disease (CMT) refers to a genetically heterogeneous group of disorders which cause a peripheral motor and sensory neuropathy. The overall prevalence is 1 in 2500 individuals. Mutations in the MFN2 gene are the commonest cause for the axonal (CMT2) type. We describe a Caucasian 5-year old girl affected by CMT2A since the age of 2 years. She presented with unsteady gait, in-turning of the feet and progressive foot deformities. Nerve conduction studies suggested an axonal neuropathy and molecular testing identified a previously reported pathogenic variant c.1090C > T, p.(Arg364Trp) in the MFN2 gene. This variant was also detected in a mosaic state in blood and saliva by Sanger sequencing in her subjectively healthy father. Next generation sequencing showed that the level of mosaicism was 21% in blood and 24% in saliva. A high recurrence risk was given because the father had proven somatic mosaicism and an affected child implying gonadal mosaicism. The parents were referred for pre-implantation genetic diagnosis. To the best of our knowledge, this is the first reported case of somatic mosaicism for MFN2. This study has important implications for genetic counselling in families with CMT2A. |
format | Online Article Text |
id | pubmed-5243894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-52438942017-02-01 Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child Schon, Katherine Spasic-Boskovic, Olivera Brugger, Kim Graves, Tracey D. Abbs, Stephen Park, Soo-Mi Ambegaonkar, Gautam Armstrong, Ruth Neurogenetics Original Article Charcot-Marie-Tooth disease (CMT) refers to a genetically heterogeneous group of disorders which cause a peripheral motor and sensory neuropathy. The overall prevalence is 1 in 2500 individuals. Mutations in the MFN2 gene are the commonest cause for the axonal (CMT2) type. We describe a Caucasian 5-year old girl affected by CMT2A since the age of 2 years. She presented with unsteady gait, in-turning of the feet and progressive foot deformities. Nerve conduction studies suggested an axonal neuropathy and molecular testing identified a previously reported pathogenic variant c.1090C > T, p.(Arg364Trp) in the MFN2 gene. This variant was also detected in a mosaic state in blood and saliva by Sanger sequencing in her subjectively healthy father. Next generation sequencing showed that the level of mosaicism was 21% in blood and 24% in saliva. A high recurrence risk was given because the father had proven somatic mosaicism and an affected child implying gonadal mosaicism. The parents were referred for pre-implantation genetic diagnosis. To the best of our knowledge, this is the first reported case of somatic mosaicism for MFN2. This study has important implications for genetic counselling in families with CMT2A. Springer Berlin Heidelberg 2017-01-06 2017 /pmc/articles/PMC5243894/ /pubmed/28063088 http://dx.doi.org/10.1007/s10048-016-0504-2 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Schon, Katherine Spasic-Boskovic, Olivera Brugger, Kim Graves, Tracey D. Abbs, Stephen Park, Soo-Mi Ambegaonkar, Gautam Armstrong, Ruth Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title | Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title_full | Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title_fullStr | Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title_full_unstemmed | Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title_short | Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child |
title_sort | mosaicism for a pathogenic mfn2 mutation causes minimal clinical features of cmt2a in the parent of a severely affected child |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243894/ https://www.ncbi.nlm.nih.gov/pubmed/28063088 http://dx.doi.org/10.1007/s10048-016-0504-2 |
work_keys_str_mv | AT schonkatherine mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT spasicboskovicolivera mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT bruggerkim mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT gravestraceyd mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT abbsstephen mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT parksoomi mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT ambegaonkargautam mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild AT armstrongruth mosaicismforapathogenicmfn2mutationcausesminimalclinicalfeaturesofcmt2aintheparentofaseverelyaffectedchild |